CenterBook Partners LP trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 83.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,704 shares of the financial services provider's stock after selling 24,322 shares during the period. CenterBook Partners LP's holdings in CME Group were worth $1,232,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in CME. BlackRock Inc. bought a new stake in CME Group in the second quarter valued at approximately $6,749,965,000. Bank of America Corp DE boosted its position in CME Group by 39.1% during the 1st quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider's stock valued at $1,187,290,000 after buying an additional 1,130,587 shares during the period. Bank of New York Mellon Corp purchased a new stake in CME Group during the 2nd quarter valued at $867,313,000. Alphabet Inc. purchased a new stake in CME Group during the 2nd quarter valued at $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in CME Group in the 2nd quarter worth $629,771,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
CME Group Stock Performance
Shares of CME opened at $304.52 on Tuesday. The company has a 50-day simple moving average of $283.48 and a two-hundred day simple moving average of $280.92. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market capitalization of $109.00 billion, a PE ratio of 25.39, a price-to-earnings-growth ratio of 3.76 and a beta of 0.15. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16.
CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, topping the consensus estimate of $2.99 by $0.03. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The company had revenue of $1.74 billion for the quarter, compared to analysts' expectations of $1.71 billion. During the same period in the prior year, the firm earned $2.68 earnings per share. The firm's revenue for the quarter was up 10.6% on a year-over-year basis. On average, analysts anticipate that CME Group Inc. will post 12.34 EPS for the current fiscal year.
CME Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 30th. Investors of record on Friday, December 11th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Friday, December 11th. CME Group's dividend payout ratio (DPR) is presently 42.66%.
Analyst Upgrades and Downgrades
A number of research firms have issued reports on CME. Barclays boosted their price objective on shares of CME Group from $281.00 to $321.00 and gave the company an "equal weight" rating in a research report on Thursday, October 22nd. JPMorgan Chase & Co. upgraded shares of CME Group from an "underweight" rating to an "overweight" rating and set a $367.00 target price for the company in a report on Thursday, October 22nd. Bank of America raised their target price on CME Group from $226.00 to $230.00 and gave the stock an "underperform" rating in a research note on Thursday, July 23rd. CLSA set a $367.00 target price on CME Group in a report on Thursday, October 22nd. Finally, Morgan Stanley raised their price target on CME Group from $337.00 to $359.00 and gave the stock an "overweight" rating in a research note on Thursday, October 22nd. Ten investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, CME Group presently has a consensus rating of "Hold" and an average price target of $314.44.
Read Our Latest Report on CME Group
Insider Buying and Selling
In other CME Group news, insider Julie Winkler sold 10,079 shares of the company's stock in a transaction dated Monday, November 2nd. The shares were sold at an average price of $305.15, for a total value of $3,075,606.85. Following the sale, the insider owned 21,482 shares in the company, valued at approximately $6,555,232.30. This represents a 31.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Howard J. Siegel sold 2,000 shares of the company's stock in a transaction dated Monday, November 2nd. The stock was sold at an average price of $303.00, for a total transaction of $606,000.00. Following the completion of the sale, the director owned 19,873 shares in the company, valued at approximately $6,021,519. This trade represents a 9.14% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 32,979 shares of company stock worth $9,552,762 over the last 90 days. Corporate insiders own 0.30% of the company's stock.
CME Group Company Profile
(
Free Report)
CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals.
The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.
CME Group was formed in 2007 through the merger of the Chicago Mercantile Exchange and the Chicago Board of Trade, institutions with roots in the 19th century.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
